G1 Therapeutics Announces Addition of Norman E. Sharpless :

RESEARCH TRIANGLE PARK, N.C., July 25, 2022 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today...

Related Keywords

Massachusetts , United States , Normane Ned Sharpless , Jack Bailey , School Of Medicine , National Cancer Institute , National Institutes Of Health , Drug Administration , Wellcome Distinguished Professor In Cancer Research , University Of North Carolina , Harvard Medical School , Nasdaq , Exchange Commission , Lineberger Comprehensive Cancer Center , Therapeutics Inc , Research Triangle Park , Investor Relations Corporate Communications , National Institutes , Chief Executive Officer , Artificial Intelligence , Machine Learning , Acting Commissioner , North Carolina , Wellcome Distinguished Professor , Cancer Research , Massachusetts General Hospital , Partners Cancer Care , Harvard Medical , Private Securities Litigation Reform Act , Investor Relations , Nasdaq Gthx , G1 Therapeutics ,